Exagen (XGN) Cash from Financing Activities (2018 - 2026)
Exagen (XGN) reported Cash from Financing Activities of -$62000.0 for Q1 2026, up 3.12% on a YoY basis from -$60121.2 in Q1 2025, and up 83.85% quarter-over-quarter from -$384000.0 in Q4 2025.
Exagen (XGN) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Exagen has reported Cash from Financing Activities for 9 years, with the latest figure at -$62000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 3.12% year-over-year to -$62000.0; the trailing twelve-month figure through Mar 2026 stood at $24.4 million (up 3997.45% YoY), and the FY2025 full-year result was $24.4 million, up 3785.52% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$62000.0, up from -$384000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $21.9 million in Q2 2025, with the low at -$10.2 million in Q2 2023.
- Historically, Cash from Financing Activities has averaged $740529.4 across 5 years, with a median of -$108000.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities plunged 3779.55% — and 2025, when it surged 9804.87%.
- Exagen's Cash from Financing Activities stood at -$173000.0 in 2022, then retreated by 27.17% to -$220000.0 in 2023, then increased by 1.82% to -$216000.0 in 2024, then tumbled by 77.78% to -$384000.0 in 2025, then soared by 83.85% to -$62000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$62000.0 (Q1 2026), -$384000.0 (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | -62,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,000.00 |
| Mar 31, 2026 | -62,000.00 |
| Dec 31, 2025 | -384,000.00 |
| Dec 31, 2025 | -384,000.00 |
| Sep 30, 2025 | 2.95 Mn |
| Sep 30, 2025 | 2.95 Mn |
| Jun 30, 2025 | 21.93 Mn |
| Jun 30, 2025 | 21.93 Mn |
| Mar 31, 2025 | -64,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Sep 30, 2024 | -121,000.00 |
| Sep 30, 2024 | -121,000.00 |
| Jun 30, 2024 | -226,000.00 |
| Jun 30, 2024 | -226,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -220,000.00 |
| Dec 31, 2023 | -220,000.00 |